Evidence map›Paper›PMID 25598555›Full record

ArticlePure and applied chemistry. Chimie pure et appliquee2012

Conformationally Constrained and Nanoparticle Targeted Paclitaxels.

David G I Kingston, Lawrence Tamarkin, Giulio F Paciotti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pure and applied chemistry. Chimie pure et appliquee, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Investigation of Vietnamese plants for potential anticancer agents.Phytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David G I KingstonDepartment of Chemistry, Virginia Tech, Blacksburg, Virginia 24061, USA.
Lawrence TamarkinCytImmune Sciences, Inc. 105010 Broschart Rd, Rockville, MD 20850, USA.
Giulio F PaciottiCytImmune Sciences, Inc. 105010 Broschart Rd, Rockville, MD 20850, USA.

Funding

STUDIES OF TUBULIN-INTERACTIVE ANTICANCER DRUGSR01CA069571 · NCI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI KINGSTON, DAVID GEORGE IAN · 1996 to 2008
$2.6M
Development of Tumor-Targeted Pegylated Colloidal Gold *R43CA119399 · NCI · CYTIMMUNE SCIENCES, INC. · PI PACIOTTI, GIULIO FRANCO · 2006 to 2007
$500k
NCI NIH HHS R01 CA069571NCI NIH HHS R43 CA119399
6 · The paper itself

Abstract

Paclitaxel (Taxol

Identifiers

PMID25598555
PMCPMC4295212

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.